EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force

@article{Andersen2012EFNSGO,
  title={EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force},
  author={Peter Munch Andersen and Sharon Abrahams and Gian Domenico Borasio and Mamede de Carvalho and Adriano Chi{\`o} and Philip van Damme and Orla Hardiman and Katja Kollewe and Karen E. Morrison and Susanne Petri and Pierre Pradat and Vincenzo Silani and Barbara Tomik and Maria Wasner and Markus Weber},
  journal={European Journal of Neurology},
  year={2012},
  volume={19}
}
Background:  The evidence base for the diagnosis and management of amyotrophic lateral sclerosis (ALS) is weak. 

Improving symptom management for people with amyotrophic lateral sclerosis

This work aims to report the prevalence of ALS‐related symptoms and characterize self-reported symptomatic management, and to characterize self‐reported symptodic management.

Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres

Evaluated the extent to which the 2005 recommendations of the European Federation of Neurological Sciences on the multidisciplinary management of amyotrophic lateral sclerosis are followed in clinical practice.

A Look at the Diversity in Management of Respiratory Failure in Amyotrophic Lateral Sclerosis

A prospective study of medically stable subjects with amyotrophic lateral sclerosis to determine possible clinical or functional predictors of need for noninvasive ventilation (NIV) during an acute lower respiratory tract infection.

Amyotrophic Lateral Sclerosis (ALS) Genetic Testing

  • Medicine
  • 2019
The Escorial Criteria were developed in 2000 to standardize the clinical diagnosis of ALS and include the presence of upper and lower motor neuron deterioration, the progressive spread of symptoms, and no clinical evidence of other diseases with similar symptoms.

Canadian best practice recommendations for the management of amyotrophic lateral sclerosis

KEY POINTS Amyotrophic lateral sclerosis (ALS) is a debilitating, progressive disease with degeneration of motor neurons in the brain and spinal cord causing weakness, muscle atrophy, fasciculations

Multidisciplinary care in amyotrophic lateral sclerosis: a 4-year longitudinal observational study.

Over a four-year period, ALS patients complied with the modalities of the multidisciplinary management follow-up without any drop-outs. The multidisciplinary management structure also contributes to

Patients with sporadic and familial amyotrophic lateral sclerosis found value in genetic testing

This research presents a novel probabilistic procedure that allows for the selection of a single gene for the treatment of ALS in patients with a history of multiple sclerosis.

Neck flexor weakness at diagnosis predicts respiratory impairment in amyotrophic lateral sclerosis

The purpose was to assess the prognostic role of neck muscle weakness at diagnosis in amyotrophic lateral sclerosis (ALS) patients with respect to survival and respiratory impairment.

The development and implications of guidelines for care of people with amyotrophic lateral sclerosis

The care of a patient with amyotrophic lateral sclerosis is complex and involved a wide multidisciplinary team, and recent guidelines in the UK look at the recommendations and implications for practice.

Development of a model to guide decision making in amyotrophic lateral sclerosis multidisciplinary care

Patients with amyotrophic lateral sclerosis (ALS) face numerous decisions for symptom management and quality of life. Models of decision making in chronic disease and cancer care are insufficient for
...

References

SHOWING 1-10 OF 198 REFERENCES

Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: A prospective study

Early and accurate diagnosis of amyotrophic lateral sclerosis (ALS) is important for patient care and for entry in clinical trials. Retrospective studies suggest that the use of the Awaji algorithm

Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study

The functional status of patients immediately before death was determined and the causes of death and the circumstances surrounding death in 302 patients with amyotrophic lateral sclerosis were investigated.

Nutritional management in MND/ALS patients: an evidence based review

  • C. HeffernanC. Jenkinson P. Sidhu
  • Medicine
    Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases
  • 2004
This systematic review addresses the evidence in regard to the management of nutrition for patients with motor neurone disease (MND), in particular amyotrophic lateral sclerosis (ALS). The aim is to

The management of amyotrophic lateral sclerosis

The terms amyotrophic lateral sclerosis (ALS) or motor neuron disease (MND) refer to a condition characterized by motor system degeneration with relative preservation of other pathways. Although

Frontal‐lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis

This work aimed to determine the prevalence of frontal‐lobe mediated behavioral impairment in Amyotrophic Lateral Sclerosis and to ascertain its relationship to cognitive impairment.

The Management of Motor Neuron Disease

This video explains how to identify and treat the early signs of motor neuron disease, and some of the symptoms can be frightening to those who have never experienced them.

Non‐invasive ventilation in ALS: current practice and future role

  • S. BourkeG. J. Gibson
  • Medicine, Psychology
    Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases
  • 2004
The current practice and future role of non‐invasive ventilation in ALS and other Motor Neuron Disorders is reviewed.

Anxiety undermines quality of life in ALS patients and caregivers

This data indicates that anxiety is a major risk factor for depression in patients with amyotrophic lateral sclerosis and the use of medication to treat anxiety is recommended.

Fatigue in amyotrophic lateral sclerosis.

  • J. Lou
  • Medicine
    Physical medicine and rehabilitation clinics of North America
  • 2008

The amyotrophic lateral sclerosis center: a model of multidisciplinary management.

...